(Q40827292)

24 September 2017

title

Reconstitution of antigen presentation in HLA class I-negative cancer cells with peptide-beta2m fusion molecules (English)

1 reference

24 September 2017

4

1 reference

24 September 2017

Tafuro S

1

1 reference

24 September 2017

Meier UC

2

1 reference

24 September 2017

Dunbar PR

3

1 reference

24 September 2017

Layton GT

5

1 reference

24 September 2017

Hunter MG

6

1 reference

24 September 2017

Bell JI

7

1 reference

24 September 2017

McMichael AJ

8

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

European Journal of Immunology

24 September 2017

published in

1 reference

24 September 2017

volume

31

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

440-449

1 reference

The HLA crossroad in tumor immunology

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Mechanisms of loss of HLA class I expression on colorectal tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Tumor cells cotransduced with B7.1 and gamma-IFN induce effective rejection of established parental tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Cells expressing a major histocompatibility complex class I molecule with a single covalently bound peptide are highly immunogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Expression of a single-chain HLA class I molecule in a human cell line: presentation of exogenous peptide and processed antigen to cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Three-dimensional structure of a peptide extending from one end of a class I MHC binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Phenotypic analysis of antigen-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Structural and functional analysis of beta2 microglobulin abnormalities in human lung and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Cancer gene therapy: hard lessons and new courses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

In vivo cell type-specific gene delivery with retroviral vectors that display single chain antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Tissue-specific targeting of retroviral vectors through ligand-receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Excess β2 microglobulin promoting functional peptide association with purified soluble class I MHC molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Assembly of MHC class I molecules analyzed in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Loss of HLA molecules in B lymphomas is associated with an aggressive clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

In vitro-isolated human cytotoxic T-lymphocyte clones detect variations in serologically defined HLA antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200102%2931%3A2%3C440%3A%3AAID-IMMU440%3E3.0.CO%3B2-0

10.1002/1521-4141(200102)31:2<440::AID-IMMU440>3.0.CO;2-0

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference